Vibliome Therapeutics, LLC
Pharmaceutical Manufacturing
Bozeman, Montana 551 followers
Highly Selective Small Molecule Kinase Inhibitors
About us
Vibliome Therapeutics, LLC, developed a novel systematic approach that enables the design of small molecule kinase inhibitors with unique selectivity profiles and extraordinary selectivity. There are over 500 kinases in the human genome which control nearly all cellular functions by transferring a polar phosphate group from ATP to regulatory serine, threonine, or tyrosine residues on proteins.
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1 employee
- Headquarters
- Bozeman, Montana
- Type
- Privately Held
- Founded
- 2017
- Specialties
- oncology, kinase inhibitors, biotechnology, and research
Locations
-
Primary
Get directions
400 E Babcock St
Bozeman, Montana 59715, US
-
Get directions
345 Park Ave S
New York, 10010, US